All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HGP2304-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HGP2304-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HIP0612Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Gastric Ulcer

  • HIP2602Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HLX04-OPhase 31 trial

    Shanghai Henlius Biotech · Age Related Macular Degeneration

  • HLX11Phase 31 trial

    Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer

  • HLX13Phase 31 trial

    Shanghai Henlius Biotech · Hepatocellular Carcinoma (HCC)

  • HLX15Phase 31 trial

    Shanghai Henlius Biotech · Newly Diagnosed Multiple Myeloma

  • HLX17Phase 31 trial

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer

  • HMI-115Phase 31 trial

    Hope Medicine (Nanjing) Co., Ltd · Endometriosis

  • HMPL-760Phase 31 trial

    Hutchmed · Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • HPP2002-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2003-3Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2201Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Gastric Ulcer

  • HPP2202Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Gastric Ulcer

  • HPP2602-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HPP2602-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

  • HPP737Phase 31 trial

    Newsoara Biopharma Co., Ltd. · Psoriasis

  • HR-1703Phase 31 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma With Eosinophilic Phenotype

  • HR070803Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Colorectal Cancer

  • HR091506Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Gout With Hyperuricemia in Adults

  • HR20013Phase 31 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents

  • HRS-4357Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

  • HRS8179Phase 31 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Severe Cerebral Edema Following Large Hemispheric Infarction

  • HS-10370Phase 31 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Carcinoma, Non-Small-Cell Lung

  • HS-10504Phase 31 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced or Metastatic NSCLC

  • HS-20117PM1080Phase 31 trial

    Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer

  • HS627Phase 31 trial

    BioRay Pharmaceutical Co., Ltd. · Breast Cancer

  • HSK16149Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · Central Neuropathic Pain

  • HSK3486Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · General Anesthetic

  • HU-045Phase 31 trial

    Huons Biopharma · Glabellar Lines

  • hu1418K322APhase 31 trial

    Renaissance Pharma Ltd. · High-Risk Neuroblastoma

  • Wanbangde Pharmaceutical Group Co., LTD · Alzheimer Dementia

  • HX22Phase 31 trial

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • I004Phase 31 trial

    Amphastar Pharmaceuticals, Inc. · Pharmacokinetics, Pharmacodynamics, Insulin Aspart

  • IAE0972Phase 31 trial

    SUNHO(China)BioPharmaceutical CO., Ltd. · NPC, HNSCC, Recurrence

  • IAH0968Phase 31 trial

    SUNHO(China)BioPharmaceutical CO., Ltd. · Stomach Neoplasms, Solid Tumor

  • IBI3027Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • IBI306Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

  • IBP-9414Phase 31 trial

    Infant Bacterial Therapeutics · Necrotizing Enterocolitis

  • iCM012Phase 31 trial

    iCoat Medical AB · Ischemia-reperfusion Injury, Kidney Transplant; Complications

  • IcotinibPhase 31 trial

    Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy

  • IDRX-42velzatinib - subject to USAN approvalPhase 31 trial

    GSK · Gastrointestinal Neoplasms

  • IgPro20Immune Globulin 20% LiquidPhase 31 trial

    CSL Behring · Secondary Immune Deficiency

  • IHL-42XInvestigational Product - IHL-42X, Optimal DosePhase 31 trial

    Incannex Healthcare Ltd · Obstructive Sleep Apnea

  • Ilaprazolethe brand name, NoltecPhase 31 trial

    Il-Yang Pharm. Co., Ltd. · Peptic Ulcer

  • IMP4927Phase 31 trial

    Impact Therapeutics, Inc. · Ovarian Cancer

  • INBRX-106OrdastobartPhase 31 trial

    Inhibrx Biosciences, Inc · Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

  • INCA033989Phase 31 trial

    Incyte · Essential Thrombocythemia

  • INCB161734Phase 31 trial

    Incyte · Solid Tumors

NewerPage 24 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.